Ceramide LIPIDOMIX Product number 330712
TM
Ceramides have significant clinical implications with regards to inflammation, immune response, and a variety of diseases. Ceramide LIPIDOMIX was developed to provide a clinically relevant ceramide mixture, and as suc1h it contains several key ceramides shown to be correlated to cardiovascular disease.
Compound name
Exact mass
Chemical formula
Target conc (µM)
Target conc (µg/mL)
C16 Ceramide (d18:1/16:0)
537.512
C 34 H 67 NO 3 C 36 H 71 NO 3 C 42 H 83 NO 3 C 42 H 81 NO 3
30
16.1
C18 Ceramide (d18:1/18:0)
565.543
15
8.5
C24 Ceramide (d18:1/24:0)
649.637
75
48.8
C24:1 Ceramide (d18:1/24:1(15Z))
647.622
37.5
24.3
1 European Heart Journal, Volume 37, Issue 25, 1 July 2016, Pages 1967–1976, https://doi.org/10.1093/eurheartj/ehw148
SPLASH II Product number 330709 TM
SPLASH II is a variation on the original SPLASH designed for plasma lipidomics. Modifications include the addition of plasmalogens and the removal of cholesterol, PG, PA, and MAG.
Compound name
Exact mass
Chemical formula
Target conc (µM)
Target conc (µg/mL)
15:0-18:1(d7) PC
752.61
C 41 H 73 D 7 NO 8 P C 38 H 67 D 7 NO 8 P
210
158.2
15:0-18:1(d7) PE
710.56
7
5
15:0-18:1(d7) PS (Na Salt)
776.53
C 39 H 66 D 7 NNaO 10 P C 42 H 75 D 7 NO 13 P C 26 H 45 D 7 NO 7 P
10
7.8
15:0-18:1(d7) PI (NH4 Salt)
846.6
10
8.5
18:1(d7) Lyso PC
528.39
45
23.80
1.0
18:1(d7) Lyso PE
486.35
C 23 H 39 D 7 NO 7 P
0.50
18:1(d7) Chol Ester
657.64
C 45 H 71 D 7 O 2
530
348.80
C18(Plasm)-18:1(d9) PC
780.67
C 44 H 77 D 9 NO 7 P
10
7.80
15:0-18:1(d7) DAG
587.55
C 36 H 61 D 7 O 5 C 51 H 89 D 7 O 6
20
11.80
15:0-18:1(d7)-15:0 TAG
811.77
70
56.90
d18:1-18:1(d9) SM
737.64
C 41 H 72 D 9 N 2 O 6 P C 41 H 71 D 9 NO 7 P
40
29.50
C18(Plasm)-18:1(d9) PE
738.62
0.1
0.07
www.avantiresearch.com
14
Made with FlippingBook - professional solution for displaying marketing and sales documents online